Inhibition of pancreatic lipase

Impact: Economic, commercial and technological

Description of impact

Named inventor on International Patent. The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.
Category of impactEconomic, commercial and technological